Trump Has ‘Small,’ ‘Distant Link’ To Sanofi, French Drugmaker Of Hydroxychloroquine

Topline: President Trump—increasingly a booster of hydroxychloroquine as a potential treatment for coronavirus—has a “small personal financial interest” in Sanofi, a French drugmaker that produces a brand-name version of the drug—though it’s a tiny investment for the billionaire.

Sanofi produces Plaquenil, the brand-name form of hydroxychloroquine, the New York Times reported; the drug is typically used to treat rheumatoid arthritis, lupus and malaria.
Trump’s three family trusts have investments in a Dodge & Cox mutual fund, with Sanofi as the largest holding, according to the Times.
Forbes estimates the value of Trump’s Sanofi holdings to be less than $3,000; for context, Forbes estimates Trump's total net worth at $2.1.